Connect your AI

Arcus Biosciences RCUS Earnings yield

Earnings yield at other companies

Bristol-Myers SquibbBMY

5.9%+1.6pp

Merck & Co.MRK

3%-4.7pp

Regeneron PharmaceuticalsREGN

5.4%-1.1pp

AbbVieABBV

0.9%-0.2pp

ImmunomeIMNM

-9.1%-3.9pp

IDEAYA Biosciences, Inc.IDYA

-4.8%-2.1pp

Other financials

Income statement

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Calculated from Arcus Biosciences’s reported figures.

net income/market cap=-13.6%

Based on trailing twelve months.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Arcus Biosciences's earnings yield?: Arcus Biosciences (RCUS) reported earnings yield of -13.6% in Q1 2026.
How has Arcus Biosciences's earnings yield changed year-over-year?: Arcus Biosciences's earnings yield increased by 71.0% year-over-year, from -47.1% to -13.6%.
What is the long-term trend for Arcus Biosciences's earnings yield?: Over 5 years (2020 to 2025), Arcus Biosciences's earnings yield has grown at a 12.2% compound annual growth rate (CAGR), from -6.7% to -12%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.